Comin et al. found CD15 to be the most specific marker in differentiating mesotheliomas from adenocarcinomas—only 4.5% of mesothelioma cases but 100% of adenocarcinoma cases expressed CD15 [54]. Here, FUT4 is linked to mesothelioma.